[

oxford-astrazeneca

]
PAGE 2
A vial and syringe are seen in front of a displayed AstraZeneca logo.(Reuters)

Thailand approves AstraZeneca vaccine amid second virus wave

Bloomberg |
PUBLISHED ON JAN 21, 2021 05:27 PM IST
Thailand’s Food and Drug Administration granted the approval for the vaccine on Thursday, Health Minister Anutin Charnvirakul said by phone. AstraZeneca is the first coronavirus vaccine developer to win approval in Thailand, which also has ordered shots developed by China’s Sinovac Biotech Ltd.
A vial and syringe are seen in front of a displayed AstraZeneca logo.(Reuters)
A vial and syringe are seen in front of a displayed AstraZeneca logo.(Reuters)

Bhutan to receive Oxford-AstraZeneca Covid-19 vaccine from India

ANI |
PUBLISHED ON JAN 18, 2021 09:41 PM IST
This comes after the Nepal Government approved the emergency use of the 'Covishield' vaccine last week, which is being manufactured by the Serum Institute of India (SII).
Vials and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020.(REUTERS FILE)
Vials and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020.(REUTERS FILE)

‘Ready to roll-out’: Adar Poonawala after Covishield, Covaxin win limited use nod

New Delhi, Hindustan Times | By Rhythma Kaul
UPDATED ON JAN 03, 2021 12:50 PM IST
The drugs controller announced that he accepted recommendations made by the subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Friday and Saturday to grant restricted emergency approval to both the vaccines
Serum Institute of India, the India partner of Oxford-Astrazeneca vaccine candidate, said it is going through all data pertaining to trials in India.(REUTERS)
Serum Institute of India, the India partner of Oxford-Astrazeneca vaccine candidate, said it is going through all data pertaining to trials in India.(REUTERS)

No need to panic, says Serum Institute of India amid concerns over Oxford-Astrazeneca trial error

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Poulomi Ghosh
UPDATED ON NOV 27, 2020 07:05 AM IST
Trials in India are going on smoothly, Pune-Based Serum Institute has confirmed after Astrazeneca admitted a dosing error which raises questions over its efficacy claim as well.
SHARE
  • 1
  • 2
Story Saved